Jill Westmoreland
About Jill Westmoreland
Jill Westmoreland is the Manager II of Preclinical Quality at Boston Scientific and the owner of Seon Marie Designs, a custom jewelry and home arts design store.
Current Role at Boston Scientific
Jill Westmoreland holds the position of Manager II, Preclinical Quality at Boston Scientific in St Paul, Minnesota. In this role, she oversees preclinical quality measures, ensuring that standards and regulations are strictly followed. Her expertise in quality management is pivotal in maintaining the integrity of the preclinical research and testing processes within the company.
Previous Roles at Boston Scientific
Jill Westmoreland has an extensive history at Boston Scientific, spanning multiple roles over a decade. She started as a Sr Business Process Analyst (2006-2009), moved to Manager I, Quality (2009-2011), then progressed to Manager II, Preclinical RTC Operations (2011-2016), before taking her current manager role in preclinical quality. This trajectory indicates her growing responsibility and expertise in quality management within the company.
Education and Expertise
Jill Westmoreland graduated from the University of Saint Thomas with a BA in Biology, studied from 1997 to 2002. Her educational background in biology has equipped her with a solid foundation for her roles in quality management, particularly in the medical devices sector at Boston Scientific.
Founder of Seon Marie Designs
In 2020, Jill Westmoreland founded Seon Marie Designs, a custom jewelry and home arts design store based in Eagan, MN. This venture showcases her entrepreneurial spirit and passion for artistic design, diversifying her professional portfolio beyond the medical and scientific fields.
Managerial Experience in Quality Management
Jill Westmoreland brings over a decade of managerial experience in quality management at Boston Scientific. Her progression from a Sr Business Process Analyst to various managerial roles underscores her ability to lead and manage quality assurance and operations within a highly regulated industry. Her current role as Manager II, Preclinical Quality, highlights her extensive experience and commitment to maintaining high standards in preclinical research.